Usefulness of 18F-FDG PET/CT in recurrent basal cell carcinoma: Report of a case

被引:2
作者
Ayala, S. [1 ,2 ]
Perlaza, P. [1 ]
Puig, S. [3 ]
Prats, E. [2 ]
Vidal-Sicart, S. [1 ]
机构
[1] Hosp Clin Barcelona, Serv Med Nucl CDIC, Barcelona, Spain
[2] Hosp Clin Univ Lozano Blesa, Serv Med Nucl, Zaragoza, Spain
[3] Hosp Clin Barcelona, Serv Dermatol ICMiD, Unitat Melanoma, Barcelona, Spain
来源
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR | 2016年 / 35卷 / 02期
关键词
Basal cell carcinoma; Local recurrence; PET/CT; Skin cancer;
D O I
10.1016/j.remn.2015.08.009
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We analyze the case of a patient with left periorbital infiltrating basal cell carcinoma treated with surgical excision in October 2010. Surgery included orbital exenteration and reconstruction using skin graft and radiotherapy. In May 2013 a MR imaging showed a mass in the left orbital fossa, suggesting a recurrence in the graft. A basal cell carcinoma recurrence with perineural invasion was confirmed in the biopsy. On F-18-FDG PET/CT performed, a hypermetabolic activity was observed in the left periorbital area with extension to surrounding sinus and bones. The use of F-18-FDG PET/CT in patients with advanced basal cell carcinoma has not been fully explored due to the rarity of this entity. This case demonstrates the usefulness of this technique to determine the extent of non-melanocytic recurrent skin tumors, and its value in the staging and treatment control, supporting the incorporation of F-18-FDG PET/CT in the management of advanced basal cell carcinoma. (C) 2015 Elsevier Espana, S.L.U. and SEMNIM. All rights reserved.
引用
收藏
页码:124 / 126
页数:3
相关论文
共 50 条
  • [31] Direct comparison of 18F-FDG PET and PET/CT in patients with colorectal carcinoma
    Cohade, C
    Osman, M
    Leal, J
    Wahl, RL
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (11) : 1797 - 1803
  • [32] Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis
    Tang, Shuang
    Huang, Gang
    Liu, Jianjun
    Liu, Tao
    Treven, Lyndal
    Song, Saoli
    Zhang, Chenpeng
    Pan, Lingling
    Zhang, Ting
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2011, 78 (01) : 142 - 150
  • [33] Role of 18F-FDG PET-CT in head and neck squamous cell carcinoma
    Castaldi, P.
    Leccisotti, L.
    Bussu, F.
    Micciche, F.
    Rufini, V.
    [J]. ACTA OTORHINOLARYNGOLOGICA ITALICA, 2013, 33 (01) : 1 - 8
  • [34] The Clinical Usefulness of 18F-FDG PET/CT in Patients with Systemic Autoimmune Disease
    Oh J.-R.
    Song H.-C.
    Kang S.-R.
    Yoo S.-W.
    Kim J.
    Chong A.
    Min J.-J.
    Bom H.-S.
    Lee S.-S.
    Park Y.-W.
    [J]. Nuclear Medicine and Molecular Imaging, 2011, 45 (3) : 177 - 184
  • [35] Thymic Small Cell Neuroendocrine Carcinoma Displayed on 18F-FDG PET/CT Imaging
    Jiang, Lei
    Li, Yanli
    Luan, Lijuan
    Zhang, Yongxing
    Shi, Hongcheng
    [J]. CLINICAL NUCLEAR MEDICINE, 2016, 41 (05) : 382 - 384
  • [36] A Case of Olfactory Neuroblastoma Detected by 18F-FDG PET/CT
    Tanaka, Kenichi
    Yamamoto, Yuka
    Hoshikawa, Hiroshi
    Nishiyama, Yoshihiro
    [J]. CLINICAL NUCLEAR MEDICINE, 2014, 39 (07) : 635 - 636
  • [37] An Unusual Case of Esophageal Carcinosarcoma on 18F-FDG PET/CT
    Li, Chongjiao
    Tian, Yueli
    Chen, Jie
    Wen, Bing
    He, Yong
    [J]. CLINICAL NUCLEAR MEDICINE, 2021, 46 (08) : 659 - 660
  • [38] The value of 18F-FDG PET/CT in Langerhans cell histiocytosis
    Rongchen An
    Xiaowei Ma
    Yunhua Wang
    [J]. Annals of Nuclear Medicine, 2024, 38 : 238 - 245
  • [39] Value of 18F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With 18F-FDG PET/CT, MRI, and Contrast-Enhanced CT
    Wang, Fei
    Guo, Rui
    Zhang, Yan
    Yu, Boqi
    Meng, Xiangxi
    Kong, Hanjing
    Yang, Yang
    Yang, Zhi
    Li, Nan
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] The value of 18F-FDG PET/CT in Langerhans cell histiocytosis
    An, Rongchen
    Ma, Xiaowei
    Wang, Yunhua
    [J]. ANNALS OF NUCLEAR MEDICINE, 2024, 38 (03) : 238 - 245